Literature DB >> 11804749

Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor.

L Mortier1, P Marchetti, E Delaporte, E Martin de Lassalle, P Thomas, F Piette, P Formstecher, R Polakowska, P-M Danzé.   

Abstract

Actinic keratoses (AKs) are pre-neoplastic lesions that can develop into squamous cell carcinomas (SCCs) of the skin. Often AK and SCC have commonly altered p53. A status of another tumor suppressor, the p16(INK4a), was reported for SCC but not for AK. A comparative study of SCC and AK human samples by loss of heterozygosity (LOH) analysis determined that the p16(INK4a/ARF) locus is less frequently altered in AKs than in SCCs. These LOH data highly correlated with immunohistochemical findings demonstrating the presence of p16(INK4a) in the AK skin samples but its absence in SCC lesions. Our results imply that progression of AK into SCC may involve inactivation of p16(INK4a).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804749     DOI: 10.1016/s0304-3835(01)00757-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Skin cancer in transplant recipients, out of the woods. Scientific retreat of the ITSCC and SCOPE.

Authors:  O R Colegio; E M Billingsley
Journal:  Am J Transplant       Date:  2011-08       Impact factor: 8.086

Review 2.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

Authors:  Vladimir Ratushny; Michael D Gober; Ryan Hick; Todd W Ridky; John T Seykora
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

3.  Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.

Authors:  Aleksandra Rymsza; Karolina Świerczyńska; Aleksandra Piotrowska; Piotr Dzięgiel; Jacek C Szepietowski
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

4.  Claudins 1, 2, 3, 4, 5 and 7 in solar keratosis and squamocellular carcinoma of the skin.

Authors:  Hanna-Riikka Hintsala; Maria Siponen; Kirsi-Maria Haapasaari; Peeter Karihtala; Ylermi Soini
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

5.  [Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy].

Authors:  J Reifenberger; M P Schön
Journal:  Hautarzt       Date:  2003-12       Impact factor: 0.751

Review 6.  How to treat actinic keratosis? An update.

Authors:  Claudia Costa; Massimiliano Scalvenzi; Fabio Ayala; Gabriella Fabbrocini; Giuseppe Monfrecola
Journal:  J Dermatol Case Rep       Date:  2015-06-30

Review 7.  Early cancers of the skin: clinical, histopathological, and molecular characteristics.

Authors:  Minoru Takata; Toshiaki Saida
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.850

8.  Genomic instability in human actinic keratosis and squamous cell carcinoma.

Authors:  Luciana Sanches Cabral; Cyro Festa Neto; José A Sanches; Itamar R G Ruiz
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.

Authors:  Sarah E Gray; Elaine Kay; Mary Leader; M Mabruk
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

10.  Actinic keratosis: rationale and management.

Authors:  Annabel Dodds; Alvin Chia; Stephen Shumack
Journal:  Dermatol Ther (Heidelb)       Date:  2014-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.